Display options
Cite
Curling EM, Hayter PM, Baines AJ, et al. Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. Biochem J. 1990;272(2):333-7doi: 10.1042/bj2720333.
Curling, E. M., Hayter, P. M., Baines, A. J., Bull, A. T., Gull, K., Strange, P. G., & Jenkins, N. (1990). Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. The Biochemical journal, 272(2), 333-7. https://doi.org/10.1042/bj2720333
Curling, E M, et al. "Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture." The Biochemical journal vol. 272,2 (1990): 333-7. doi: https://doi.org/10.1042/bj2720333
Curling EM, Hayter PM, Baines AJ, Bull AT, Gull K, Strange PG, Jenkins N. Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. Biochem J. 1990 Dec 01;272(2):333-7. doi: 10.1042/bj2720333. PMID: 2125204; PMCID: PMC1149704.
Copy Download .nbib Format: NLM
Share it on
Full text links
Silverchair Information Systems Free PMC Article

Biochem J. 1990 Dec 01;272(2):333-7. doi: 10.1042/bj2720333.

Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture.

The Biochemical journal

E M Curling, P M Hayter, A J Baines, A T Bull, K Gull, P G Strange, N Jenkins

Affiliations

  1. Biological Laboratory, University of Kent, Canterbury, U.K.

PMID: 2125204 PMCID: PMC1149704 DOI: 10.1042/bj2720333
Free PMC Article

Abstract

Recombinant human interferon-gamma (Hu-IFN-gamma) produced by Chinese-hamster ovary (CHO) cells was analysed by immunoprecipitation and SDS/PAGE. Up to twelve molecular-mass variants were secreted by this cell line. Three variants were recovered after enzymic removal of all N-linked oligosaccharides or when glycosylation was inhibited by tunicamycin. The presence of three polypeptide forms rather than a single form suggested that proteolytic cleavage had occurred at two sites in both the glycosylated and non-glycosylated forms. Proteolytically cleaved IFN-gamma was more prevalent in cell lysates than in the secreted glycoprotein. In common with naturally produced IFN-gamma, both fully glycosylated IFN-gamma (asparagine residues 28 and 100 occupied) and partially glycosylated product (thought to be substituted at position Asn28) were secreted. This was deduced from the Mr of the glycosylated products and the relative amounts of sialic acid expressed by each variant. In contrast with naturally produced IFN-gamma, non-glycosylated IFN-gamma was also secreted by the transfected CHO cells. When the cells were grown in batch culture in serum-free medium under pH and dissolved-oxygen control, the proportion of non-glycosylated IFN-gamma increased from 3 to 5% after 3 h, to 30% of the total IFN-gamma present after 195 h. This change in the proportion of glycosylated protein produced was not seen when metabolically labelled IFN-gamma was incubated for 96 h with cell-free supernatant from actively growing CHO cells. This implied that an alteration in intracellular glycosylation was occurring rather than a degradation of oligosaccharide side chains after secretion. The decrease in IFN-gamma glycosylation was independent of the glucose concentration in the culture medium, but could be related to specific growth and IFN-gamma production rates, as these declined steadily after 50 h of culture, in line with the increased production of non-glycosylated IFN-gamma.

Similar articles

Show all 21 similar articles

Cited by

References

  1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  2. Biochem J. 1990 Jun 15;268(3):777-81 - PubMed
  3. Annu Rev Biochem. 1981;50:555-83 - PubMed
  4. Nature. 1982 Feb 11;295(5849):503-8 - PubMed
  5. Annu Rev Biochem. 1982;51:531-54 - PubMed
  6. J Biol Chem. 1983 Jul 10;258(13):8010-3 - PubMed
  7. Mol Cell Biol. 1984 Jan;4(1):166-72 - PubMed
  8. J Biol Chem. 1984 Jun 10;259(11):6790-7 - PubMed
  9. J Biol Chem. 1985 Aug 15;260(17):9936-40 - PubMed
  10. Eur J Biochem. 1986 May 2;156(3):651-4 - PubMed
  11. J Biol Chem. 1986 Jun 25;261(18):8534-9 - PubMed
  12. J Biol Chem. 1987 Feb 25;262(6):2528-35 - PubMed
  13. Hybridoma. 1987 Apr;6(2):173-81 - PubMed
  14. J Interferon Res. 1987 Apr;7(2):145-54 - PubMed
  15. Annu Rev Biochem. 1987;56:497-534 - PubMed
  16. Infect Immun. 1987 Nov;55(11):2727-33 - PubMed
  17. FEBS Lett. 1988 Mar 28;230(1-2):201-4 - PubMed
  18. J Cell Biol. 1988 Apr;106(4):1049-59 - PubMed
  19. N Engl J Med. 1988 Jun 2;318(22):1409-13 - PubMed
  20. Biochemistry. 1988 Mar 22;27(6):1981-7 - PubMed
  21. J Biol Chem. 1988 Nov 25;263(33):17508-15 - PubMed
  22. J Biol Chem. 1988 Nov 25;263(33):17516-21 - PubMed
  23. Eur J Biochem. 1989 May 15;181(3):545-53 - PubMed
  24. J Biol Chem. 1989 Jul 25;264(21):12179-86 - PubMed
  25. Biochemistry. 1980 Nov 25;19(24):5619-24 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources